v3.22.2.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows from Operating Activities    
Net loss $ (1,553,643) $ (386,027)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 177,376 130,145
Amortization of convertible debt discounts and warrants 121,270 8,750
Change in fair value of derivative liability (1,008,000)
Stock issued for services and donated 385,428 32,750
Stock issued under Equity Purchase Agreement 252,900
Fair value of warrants issued 150,000
Changes in assets and liabilities:    
Accounts receivable (345,103) (61,683)
Inventories 51,399 (109,402)
Right of use assets 19,721 16,321
Accounts payable (120,178) 7,847
Accrued expenses 140,573 382,863
Deferred revenue 471,997 (139,273)
Net cash used in operating activities (501,160) (872,809)
Cash Flows from Investing Activities    
Purchases of capitalized development costs (420,559) (4,160)
Purchases of property and equipment
Net cash used in investing activities (420,559) (4,160)
Cash Flows from Financing Activities    
Principal payments on financing lease obligations (1,392)
Proceeds from notes payable 477,500
Principal payments on notes payable (245,986) (128,042)
Proceeds (payments) on notes and advances from stockholders, net 396,595 (13,998)
Proceeds (payments) on line of credit, net 155,837 (4,999)
Proceeds from sale of common stock under Equity Purchase Agreement 838,100
Net cash provided by financing activities 783,946 689,669
Net Decrease in Cash (137,773) (187,300)
Cash, Beginning of Period 300,899 541,591
Cash, End of Period 163,126 354,291
Supplemental and Non Cash Disclosures    
Legal fees netted from loan proceeds 50,413
Cash paid for interest 109,725 37,079
Settlement of note payable 400,000
Interest on shares issued under Equity Purchase Agreement 252,900
Stock issued for services 188,128 32,750
Accretion of discount and change in fair value of derivatives $ 121,270 $ 999,250